Nanexa AB
Nanexa AB (publ), a pharmaceutical company, develops injectable drug products in the Nordic countries, rest of Europe, and North America. The company offers PharmaShell, a drug delivery system based on atomic layer deposition coating technology for controlled release of various types of active pharmaceutical substances. It also develops NEX-22, a glucagon-like peptide-1 analogue liraglutide that … Read more
Nanexa AB (NANEXA) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of December 2025: 0.175x
Based on the latest financial reports, Nanexa AB (NANEXA) has a cash flow conversion efficiency ratio of 0.175x as of December 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr17.79 Million) by net assets (Skr101.53 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Nanexa AB - Cash Flow Conversion Efficiency Trend (2014–2025)
This chart illustrates how Nanexa AB's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Nanexa AB Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Nanexa AB ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Lake Shore Bancorp Inc
NASDAQ:LSBK
|
0.024x |
|
DENARIUS METALS CORP.
F:T7C0
|
N/A |
|
Regional Express Holdings Ltd
AU:REX
|
0.063x |
|
SCH Group Bhd
KLSE:0161
|
0.009x |
|
APEX International Financial Engineering Res & Tech Co Ltd
TWO:5210
|
0.016x |
|
AB Science S.A
PINK:ABSCF
|
0.149x |
|
Elementos Ltd
AU:ELT
|
-0.021x |
|
DanCann Pharma A/S
PINK:DCPXF
|
0.302x |
Annual Cash Flow Conversion Efficiency for Nanexa AB (2014–2025)
The table below shows the annual cash flow conversion efficiency of Nanexa AB from 2014 to 2025.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | Skr101.53 Million | Skr-1.46 Million | -0.014x | +96.14% |
| 2024-12-31 | Skr70.92 Million | Skr-26.43 Million | -0.373x | +16.29% |
| 2023-12-31 | Skr95.83 Million | Skr-42.66 Million | -0.445x | -516.99% |
| 2022-12-31 | Skr109.10 Million | Skr-7.87 Million | -0.072x | +56.56% |
| 2021-12-31 | Skr151.29 Million | Skr-25.13 Million | -0.166x | +57.21% |
| 2020-12-31 | Skr43.35 Million | Skr-16.83 Million | -0.388x | -2.54% |
| 2019-12-31 | Skr24.88 Million | Skr-9.42 Million | -0.379x | +8.75% |
| 2018-12-31 | Skr16.29 Million | Skr-6.76 Million | -0.415x | -124.54% |
| 2017-12-31 | Skr27.46 Million | Skr-5.07 Million | -0.185x | +51.07% |
| 2016-12-31 | Skr16.96 Million | Skr-6.41 Million | -0.378x | +30.46% |
| 2015-12-31 | Skr6.07 Million | Skr-3.29 Million | -0.543x | -241.43% |
| 2014-12-31 | Skr1.47 Million | Skr563.99K | 0.384x | -- |